Mercalis

Roughly half of new launches that miss first-year forecasts do so largely attributed to market access challenges, including patients' out-of-pocket expenses and higher than anticipated costs on discounts and rebates. Learn how to increase speed to therapy and cost savings. Read more: https://bit.ly/3UIP0IS #patientservices #marketaccess

We are honored to connect with Peter L. Saltonstall, outgoing CEO of National Organization for Rare Disorders (NORD) at their annual conference this week. Peter’s stewardship of NORD and his unwavering service to rare disease families is legendary. NORD's commitment to the rare disease community will continue to grow with Pamela Gavin, incoming CEO. We are constantly humbled by the strength of the #RareDisease community.

Today, Mercalis announces the expansion of its state-of-the-art non-commercial dispensing pharmacy, allowing pharmaceutical manufacturers to provide patient assistance program services to uninsured or underinsured patients. In addition, Mercalis provides quick-start and bridge program services that offer a limited supply of free medication to patients initiating therapy. Read the press release to learn more: https://bit.ly/3YwB7R6

Join Heather Hays, an experienced Market Access and Patient Support Strategy professional at the CCO Summit to learn how to build a Market Access hiring plan and develop the department during her presentation. Also, visit the Mercalis booth to learn how we can partner with you throughout the commercialization lifecycle: https://bit.ly/3NRjaqp #lifesciences #CCO

National Pharmacy Week recognize the powerful impact pharmacists make on their patients' lives. It is an opportunity to raise your patients’ and colleagues’ awareness about the vital role pharmacists play on the healthcare team. It also provides a meaningful way for Mercalis to affirm our staff's hard work to ensure medication use at our pharmacies are safe and patients are achieving optimal outcomes. https://bit.ly/4dzPNDe

National Organization for Rare Disorders' mission is to improve the health and well-being of people with rare diseases by driving advances in care, research and policy. Mercalis is pleased to attend their conference to discuss our advancements in patient identification and educating HCPs on rare diseases. https://bit.ly/3TebdhJ

Members of Team Mercalis were pleased to attend and support the Miracle League of the Triangle at last night’s annual gala. The Miracle League of the Triangle’s mission is to create positive life experiences for children and adults with special needs through baseball. #WeAreMercalis

Today Scott Dulitz, MBA, CEO of Mercalis was a featured panelist at #AVBCC in the session on "Biosimilars: How Are We Really Doing: Is it Survival or Extinction?" Learn how Mercalis is supporting their clients to optimize their patient services with these key strategies: https://lnkd.in/eKibtETj

What is the impact and correct balance with the usage of AI for Payers, Providers, and Patients to increase efficiencies for Prior Authorizations? Bill Dupere discusses this with fellow panelists at AVBCC. Join this session or contact us to learn more: https://bit.ly/4cSFWIQ

We are proud to sponsor AVBCC and many of our Mercalis team will be in attendance. Scott Dulitz, MBA, CEO of Mercalis is a featured panelist among others in the industry to discuss the impact of Biosimilars to the market. Join this discussion or read more about this topic here: https://bit.ly/3A3N3QJ